Phishing warning 01-May-2024
We are aware of phishing emails targeting speakers of events whose names appear on our events pages. If you are unsure if an email regarding event registration or accommodation has come from us please contact us and do not provide any credit card details or personal information.

17th Annual Drug Discovery Leaders Summit 2016

13 June 2016 07:30 - 14 June 2016 18:00, Berlin , Germany


This event is by invitation only Book now

Introduction
Oxford Global’s 17th Annual Drug Discovery Leaders Summit and our co-located 4th Annual Discovery Chemistry and Drug Design Congress is Europe’s leading Summit in the drug discovery and discovery chemistry field. Our prestigious Summit brings together prominent decision makers working at the forefront of research into target based discovery, phenotypic screening, medicinal chemistry and drug design.
 
Our Summit will consist of 7 interactive streams covering:
Target Based Discovery
Screening and Assays: Enabling Technologies
Novel Therapeutic Modalities and New Target Classes
Supporting Innovation: Data and Information Management
Discovery Chemistry: Latest Case Studies
Drug Design: Novel Approaches
Large Molecule Discovery Approaches
 
On day one our panel of discovery experts will explore the resurgence of phenotypic screening, the latest innovations in high content analysis and the most promising new therapeutic modalities such as the microbiome, natural products and new target classes. Day one also features a stream dedicated to the latest research in medicinal chemistry, including exciting protein-protein interaction updates.
 
On day two delegates will hear from our industry leaders about the most promising new large molecule discovery techniques, and our data and information management stream will host exciting discussions about how to exploit Big Data for more efficient drug discovery and our third stream is dedicated to the most innovative approaches to drug design.
 
Speakers
  • Tove Tuntland Genomics Institute Of Novartis Research Foundation (GNF), United States
  • Peter Dandliker Director, ALIS Affinity Screening, Merck, United States
  • Thomas Steger-Hartmann Head of Investigational Toxicology, Vice President, Bayer , Germany

Venue
Hotel Palace Berlin

Hotel Palace Berlin, Budapester Str. 45 , Berlin , 10787 , Germany

Organised by
Oxford Global
Contact information
Search
 
 
Showing all upcoming events
Start Date
End Date
Location
Subject area
Event type

Advertisement
Spotlight


E-mail Enquiry
*
*
*
*